Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis.
- DOI
- 10.1007/s10637-024-01503-6
- Published
- 2025-01-09
- Container
- Invest New Drugs
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10637-024-01503-6,
title = {Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis.},
author = {Shimomura K and Ogata T and Maeda A and Narita Y and Taniguchi H and Murotani K and Fujiwara Y and Tajika M and Hara K and Muro K and Uchida K.},
year = {2025},
journal = {Invest New Drugs},
doi = {10.1007/s10637-024-01503-6},
url = {https://doi.org/10.1007/s10637-024-01503-6}
}RIS
TY - JOUR TI - Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis. AU - Shimomura K AU - Ogata T AU - Maeda A AU - Narita Y AU - Taniguchi H AU - Murotani K AU - Fujiwara Y AU - Tajika M AU - Hara K AU - Muro K AU - Uchida K. PY - 2025 JO - Invest New Drugs DO - 10.1007/s10637-024-01503-6 UR - https://doi.org/10.1007/s10637-024-01503-6 ER -
APA
K, S., T, O., A, M., Y, N., H, T., K, M., Y, F., M, T., K, H., K, M., & K., U. (2025). Investigation of the association between therapeutic effectiveness of anamorelin and Glasgow prognostic score in patients with cancer cachexia: a competing risk analysis.. Invest New Drugs. https://doi.org/10.1007/s10637-024-01503-6
Source records
- europe-pmc · retrieved 2026-09-27T04:50:07.033Z